Atlas Trials

Anti-PD-1 Antibody in the Treatment of Patients With Malignant Melanoma of the Female Genital Tract

Clinical trial NCT04593485 · UNKNOWN

Trial details

NCT number
NCT04593485
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Melanoma
Start date
2020-10-28
Primary completion
2023-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.